Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Sell
46
HQH Quote, Financials, Valuation and Earnings
Last price:
$16.56
Seasonality move
:
2.07%
Day range:
$16.28 - $16.64
52-week range:
$15.76 - $19.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
288.8K
Avg. volume:
281.4K
1-year change:
-2.19%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus Ratingabrdn Healthcare Investors has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, abrdn Healthcare Investors has an estimated downside of -- from its current price of $16.55.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $16.55.
Fair Value
-
According to the consensus of 0 analysts, abrdn Healthcare Investors has -- downside to fair value with a price target of -- per share.
HQH vs. S&P 500
-
Over the past 5 trading days, abrdn Healthcare Investors has overperformed the S&P 500 by 0.48% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
abrdn Healthcare Investors does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
abrdn Healthcare Investors has grown year-over-year revenues for 0 quarters straight. In the most recent quarter abrdn Healthcare Investors reported revenues of --.
Earnings Growth
-
abrdn Healthcare Investors has grown year-over-year earnings for 0 quarters straight. In the most recent quarter abrdn Healthcare Investors reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-04 | 2024-01-04 | 2024-01-04 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2017-03-31 | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $279.6K | $11.7M | $10.4M | $356.9K | |
| Total Assets | -- | $972.2M | $967.2M | $885M | $1.1B | |
| Current Liabilities | -- | -- | $5.6M | -- | $2.6M | |
| Total Liabilities | -- | $1.2M | $6.6M | $1.1M | $3.7M | |
| Total Equity | -- | $971.1M | $960.6M | $884M | $1.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-04 | 2024-01-04 | 2024-01-04 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
HQH
Sector
Market Cap
--
--
Price % of 52-Week High
83.63%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-2.19%
--
Beta (5-Year)
0.783
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$16.36
200-day SMA
Sell
Level
$17.65
Bollinger Bands (100)
Sell
Level
17.22 - 19
Chaikin Money Flow
Buy
Level
16.1M
20-day SMA
Sell
Level
$16.72
Relative Strength Index (RSI14)
Sell
Level
43.63
ADX Line
Buy
Level
19.38
Williams %R
Neutral
Level
-52.2059
50-day SMA
Sell
Level
$17.45
MACD (12, 26)
Sell
Level
-0.35
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
26.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Stock Forecast FAQ
In the current month, HQH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HQH average analyst price target in the past 3 months is --.
-
Where Will abrdn Healthcare Investors Stock Be In 1 Year?
According to analysts, the consensus estimate is that abrdn Healthcare Investors share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About abrdn Healthcare Investors?
Analysts are divided on their view about abrdn Healthcare Investors share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that abrdn Healthcare Investors is a Sell and believe this share price will rise from its current level to --.
-
What Is abrdn Healthcare Investors's Price Target?
The price target for abrdn Healthcare Investors over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HQH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for abrdn Healthcare Investors is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HQH?
You can purchase shares of abrdn Healthcare Investors via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase abrdn Healthcare Investors shares.
-
What Is The abrdn Healthcare Investors Share Price Today?
abrdn Healthcare Investors was last trading at $16.56 per share. This represents the most recent stock quote for abrdn Healthcare Investors. Yesterday, abrdn Healthcare Investors closed at $16.55 per share.
-
How To Buy abrdn Healthcare Investors Stock Online?
In order to purchase abrdn Healthcare Investors stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
30
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
